Cite
Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective.
MLA
Board, Amy, et al. “Polysubstance Use during Pregnancy: The Importance of Screening, Patient Education, and Integrating a Harm Reduction Perspective.” Drug & Alcohol Dependence, vol. 247, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.drugalcdep.2023.109872.
APA
Board, A., D’Angelo, D. V., Salvesen von Essen, B., Denny, C. H., Miele, K., Dunkley, J., Baillieu, R., & Kim, S. Y. (2023). Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective. Drug & Alcohol Dependence, 247, N.PAG. https://doi.org/10.1016/j.drugalcdep.2023.109872
Chicago
Board, Amy, Denise V. D’Angelo, Beatriz Salvesen von Essen, Clark H. Denny, Kathryn Miele, Janae Dunkley, Robert Baillieu, and Shin Y. Kim. 2023. “Polysubstance Use during Pregnancy: The Importance of Screening, Patient Education, and Integrating a Harm Reduction Perspective.” Drug & Alcohol Dependence 247 (June): N.PAG. doi:10.1016/j.drugalcdep.2023.109872.